Evidence map›Paper›PMID 30978186›Full record

Trial reportPloS one2019

Insights into the genetic diversity of Mycobacterium tuberculosis in Tanzania.

Liliana K Rutaihwa, Mohamed Sasamalo, Aladino Jaleco, Jerry Hella, Ally Kingazi, Lujeko Kamwela, Amri Kingalu, Bryceson Malewo, Raymond Shirima, Anna Doetsch and 8 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Diagnostic accuracy of a sequence-specificMicrobiology spectrum · 2024
    Article
  2. Article
  3. Article
  4. Whole-Genome Sequencing ofMicroorganisms · 2023
    Article
  5. Article
  6. Does BCG vaccination protect against infection withThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Article
  7. Understanding the Genetic Diversity ofFrontiers in genetics · 2022
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Liliana K RutaihwaSwiss Tropical and Public Health Institute, Basel, Switzerland.
Mohamed SasamaloSwiss Tropical and Public Health Institute, Basel, Switzerland.
Aladino JalecoSwiss Tropical and Public Health Institute, Basel, Switzerland.
Jerry HellaSwiss Tropical and Public Health Institute, Basel, Switzerland.
Ally KingaziIfakara Health Institute, Bagamoyo, Tanzania.
Lujeko KamwelaSwiss Tropical and Public Health Institute, Basel, Switzerland.
Amri KingaluCentral Tuberculosis Reference Laboratory, Dar es Salaam, Tanzania.
Bryceson MalewoCentral Tuberculosis Reference Laboratory, Dar es Salaam, Tanzania.
Raymond ShirimaCentral Tuberculosis Reference Laboratory, Dar es Salaam, Tanzania.
Anna DoetschSwiss Tropical and Public Health Institute, Basel, Switzerland.
Julia FeldmannSwiss Tropical and Public Health Institute, Basel, Switzerland.
Miriam ReinhardSwiss Tropical and Public Health Institute, Basel, Switzerland.
Sonia BorrellSwiss Tropical and Public Health Institute, Basel, Switzerland.
Daniela BritesSwiss Tropical and Public Health Institute, Basel, Switzerland.
Klaus ReitherSwiss Tropical and Public Health Institute, Basel, Switzerland.
Basra DoullaCentral Tuberculosis Reference Laboratory, Dar es Salaam, Tanzania.
Lukas FennerSwiss Tropical and Public Health Institute, Basel, Switzerland.
Sebastien GagneuxSwiss Tropical and Public Health Institute, Basel, Switzerland.ORCID 0000-0001-7783-9048
Swiss Tropical and Public Health Institute · CHIfakara Health Institute · TZUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman tuberculosis (TB) is caused by seven phylogenetic lineages of the Mycobacterium tuberculosis complex (MTBC), Lineage 1-7. Recent advances in rapid genotyping of MTBC based on single nucleotide polymorphisms (SNP), allow for phylogenetically robust strain classification, paving the way for defining genotype-phenotype relationships in clinical settings. Such studies have revealed that, in addition to host and environmental factors, strain variation in the MTBC influences the outcome of TB infection and disease. In Tanzania, such molecular epidemiological studies of TB however are scarce in spite of a high TB burden. METHODS AND

findingsHere we used SNP-typing to characterize a nationwide collection of 2,039 MTBC clinical isolates representative of 1.6% of all new and retreatment TB cases notified in Tanzania during 2012 and 2013. Four lineages, namely Lineage 1-4 were identified within the study population. The distribution and frequency of these lineages varied across regions but overall, Lineage 4 was the most frequent (n = 866, 42.5%), followed by Lineage 3 (n = 681, 33.4%) and 1 (n = 336, 16.5%), with Lineage 2 being the least frequent (n = 92, 4.5%). We found Lineage 2 to be independently associated with female sex (adjusted odds ratio [aOR] 2.14; 95% confidence interval [95% CI] 1.31 - 3.50, p = 0.002) and retreatment cases (aOR 1.67; 95% CI 0.95 - 2.84, p = 0. 065) in the study population. We found no associations between MTBC lineage and patient age or HIV status. Our sublineage typing based on spacer oligotyping on a subset of Lineage 1, 3 and 4 strains revealed the presence of mainly EAI, CAS and LAM families. Finally, we detected low levels of multidrug resistant isolates among a subset of 144 retreatment cases.

conclusionsThis study provides novel insights into the MTBC lineages and the possible influence of pathogen-related factors on the TB epidemic in Tanzania.

Indexed as

PhylogenyPolymorphism, Single NucleotideAdolescentAdultAgedFemaleHumansMaleMiddle AgedMycobacterium tuberculosisTanzaniaTuberculosis, Pulmonary

Identifiers

PMID30978186
PMCPMC6461268
OpenAlexW2951356366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.